TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 9 | 38 | 39 | 61 | 60 | 40 | 41 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/20 19:05 | 12/21/19 | MIST | Milestone Pharmaceuticals Inc. | A8 | Health | Drug | Pharmaceutical Preparations | Oliveto Joseph | A8 | DO | P,CEO | M.d | 11 | 1.54 | 0 | 7 | 3 | 281 | D | ||||||||||||||
6/25/14 20:23 | 6/23/14 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Oliveto Joseph | NC | DO | P,CEO | M.d | 980 | 2.00 | 0 | 490 | 0 | D | |||||||||||||||
8/16/10 15:49 | 8/12/10 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Oliveto Joseph | NC | O | VP of Op | P.d | 10 | 2.87 | 0 | 4 | New | 4 | D | -45 | -41 | 14 | -27 | 0 | -5 | 3 | -7 | 9 | 38 | 39 | 61 | 60 | 40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |